Pathway Background and Objectives
Tonsillectomy and adenoidectomy is a common procedure with greater than 500,000 performed annually in the United States. However, there is variability in peri-operative and post-operative care for these patients. This can lead to confusion and dissatisfaction for patients, families, and providers. Additionally, guidelines were updated in 2011 in regards to peri-operative steroid use and post-operative antibiotic use. Based on these changes and through standardization of our workflows, we have applied these recommendations to provide a consistent approach to treatment of children undergoing tonsillectomy and adenoidectomy.
The specific objectives of this pathway are to:
- Standardize the management of Tonsillectomy and Adenoidectomy patients based on severity of their obstructive symptoms
- Standardize the use of medications with a goal of no perioperative antibiotics and one dose of IV steroids in the operating room